What one share of TELA Bio holds
We are a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy.
TELA Bio’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.51 |
|---|---|
| Profit | −$0.78 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.60 |
| Cash and investments | $0.68 |
| Debt | $1.25 |
| Book value | −$0.35 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $14.54 | −$93.25 | $0.39 | −$56.45 | — | −$370.50 |
| 2018 | $28.05 | −$101.41 | $0.21 | −$67.75 | — | −$466.19 |
| 2019 | $8.74 | −$17.10 | $0.11 | −$14.56 | — | — |
| 2020 | $1.41 | −$2.23 | $0.01 | −$1.90 | — | $3.40 |
| 2021 | $2.04 | −$2.30 | $0.04 | −$2.15 | — | $1.38 |
| 2022 | $2.55 | −$2.72 | $0.05 | −$2.56 | — | $0.75 |
| 2023 | $2.56 | −$2.04 | $0.03 | −$1.81 | — | $0.77 |
| 2024 | $2.43 | −$1.33 | $0.03 | −$1.49 | — | $0.72 |
| 2025 | $1.71 | −$0.83 | $0.01 | −$0.61 | — | $0.14 |
Common questions about TELA Bio
How much does one share of TELA Bio earn?
Over the last 12 months, TELA Bio lost $0.78 for each share on $1.51 of sales.
Does TELA Bio pay a dividend?
TELA Bio didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is TELA Bio’s book value per share?
TELA Bio’s book value is negative (−$0.35 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of TELA Bio have?
Each share of TELA Bio has $0.68 of cash and investments and $1.25 of debt, as of June 30, 2026.
What is TELA Bio’s free cash flow per share?
−$0.60 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has TELA Bio bought back shares?
TELA Bio’s share count rose about 15980% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.